ART-D01

N/A

Report date: 2025/02/01 20:00:06

NME

Base Information

Drug NameART-D01

Drug Alias Namerecombinant adeno-associated viral vector PBEF shRNA-based gene therapy (Arthrogen BV)ART-D01

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisenseSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > short hairpin RNA

Mechanisms of ActionChemokines inhibitorsNicotinamide phosphoribosyltransferase inhibitors

TargetsChemokinesNicotinamide phosphoribosyltransferase

Therapy Area/IndicationsArthritis, Rheumatoid

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryNetherlands

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArthrogen

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArthrogen

Active IndicationsN/A

Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A